State Street’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.31M Buy
177,768
+48,995
+38% +$360K ﹤0.01% 3434
2025
Q1
$994K Buy
128,773
+2,126
+2% +$16.4K ﹤0.01% 3428
2024
Q4
$1.53M Buy
126,647
+22,157
+21% +$268K ﹤0.01% 3395
2024
Q3
$1.31M Buy
104,490
+8,412
+9% +$105K ﹤0.01% 3433
2024
Q2
$1.15M Buy
96,078
+55,540
+137% +$663K ﹤0.01% 3454
2024
Q1
$709K Buy
40,538
+26,200
+183% +$458K ﹤0.01% 3559
2023
Q4
$368K Buy
14,338
+9,498
+196% +$244K ﹤0.01% 3717
2023
Q3
$35K Hold
4,840
﹤0.01% 4358
2023
Q2
$25.5K Hold
4,840
﹤0.01% 4558
2023
Q1
$15K Sell
4,840
-4,840
-50% -$15K ﹤0.01% 4711
2022
Q4
$38.3K Hold
9,680
﹤0.01% 4618
2022
Q3
$37K Hold
9,680
﹤0.01% 4719
2022
Q2
$129K Hold
9,680
﹤0.01% 4402
2022
Q1
$48K Hold
9,680
﹤0.01% 4801
2021
Q4
$66K Hold
9,680
﹤0.01% 4654
2021
Q3
$298K Buy
9,680
+3,893
+67% +$120K ﹤0.01% 4202
2021
Q2
$188K Sell
5,787
-44,644
-89% -$1.45M ﹤0.01% 4228
2021
Q1
$1.91M Buy
50,431
+6,373
+14% +$241K ﹤0.01% 3457
2020
Q4
$2.09M Buy
44,058
+12,807
+41% +$606K ﹤0.01% 3357
2020
Q3
$1.01M Buy
31,251
+3,880
+14% +$125K ﹤0.01% 3434
2020
Q2
$1.21M Buy
+27,371
New +$1.21M ﹤0.01% 3368
2019
Q2
Sell
-26,008
Closed -$1.58M 3832
2019
Q1
$1.58M Sell
26,008
-741
-3% -$45.1K ﹤0.01% 3232
2018
Q4
$1.58M Buy
26,749
+880
+3% +$52.1K ﹤0.01% 3206
2018
Q3
$2.09M Buy
25,869
+1,892
+8% +$153K ﹤0.01% 3229
2018
Q2
$2.1M Buy
23,977
+22,835
+2,000% +$2M ﹤0.01% 3238
2018
Q1
$221K Buy
+1,142
New +$221K ﹤0.01% 3547
2015
Q3
Sell
-23
Closed -$51K 3728
2015
Q2
$51K Sell
23
-6
-21% -$13.3K ﹤0.01% 3592
2015
Q1
$69K Hold
29
﹤0.01% 3562
2014
Q4
$60K Sell
29
-3
-9% -$6.21K ﹤0.01% 3571
2014
Q3
$63K Hold
32
﹤0.01% 3554
2014
Q2
$114K Sell
32
-554
-95% -$1.97M ﹤0.01% 3460
2014
Q1
$2.19M Buy
586
+2
+0.3% +$7.47K ﹤0.01% 3026
2013
Q4
$1.91M Buy
584
+4
+0.7% +$13.1K ﹤0.01% 3090
2013
Q3
$2.43M Buy
580
+4
+0.7% +$16.7K ﹤0.01% 2939
2013
Q2
$1.94M Buy
+576
New +$1.94M ﹤0.01% 3000